Potent ntd-targeting neutralizing antibodies against sars-cov-2 selected from a synthetic immune system

HIGHLIGHTS

• who: Wenping Li et al. from the Shanghai Institute for Advanced Immunochemical Studies, ShanghaiTech University, Shanghai, China have published the Article: Potent NTD-Targeting Neutralizing Antibodies against SARS-CoV-2 Selected from a Synthetic Immune System, in the Journal: Vaccines 2023, 11, 771. of /2023/
• what: In current study, the authors designed a selection scheme that took full advantage of the approach of CAL to identify human antibodies that recognize non-RBD epitopes of SARS-CoV-2 S protein. The authors demonstrated that epitopes of weak immunogenicity in the natural immune system could be sensitized . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.